{"nct_id":"NCT02411448","title":"A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-04","start_date":"2015-05-06","start_date_type":"ACTUAL","primary_completion_date":"2019-01-23","primary_completion_date_type":"ACTUAL","completion_date":"2025-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["LLY"]}